FBIO ææ°ååæã®æ±ºç®å ±åæž
çºè¡šæ¥8/13/2026
EPSå®çžŸïŒUSDïŒ-0.08
売äžé«å®çžŸïŒUSDïŒ18.72M
Fortress Biotech Incã®æ±ºç®æ¥ã»å ±åæž
ãã®ããŒãžã§ã¯ãææ°ã® Fortress Biotech Inc ã®æ±ºç®å ±åæžã次å Fortress Biotech Inc ã®æ±ºç®äºå®æ¥ãéå»ã®ããŒã¿ãFortress Biotech Inc ã®æ±ºç®é»è©±äŒè°ãã¥ãŒã¹ãªã©ã詳现㪠Fortress Biotech Inc ã®æ±ºç®ããŒã¿ãæäŸããŠããŸãã
FBIO 次åååæã®æ±ºç®çºè¡šæ¥
çºè¡šæ¥--
EPSäºæ³ïŒUSDïŒ--
売äžé«äºæ³ïŒUSDïŒ--
FBIO FY2025 決ç®
EPS (å幎åææ¯)-0.0797.49%
売äžé« (å幎åææ¯)63.26M9.69%
Fortress Biotech IncïŒFBIOïŒã®æ±ºç®å±¥æŽ
| å ¬éæ¥ | 察象æéçµäº | EPS/äºæž¬ | åç/äºæž¬ | EPSãµãã©ã€ãº % | 売äžé«ãµãã©ã€ãº % |
|---|---|---|---|---|---|
| 8/13/2026 | 06/2026 | -0.08/-0.20 | 18.72M/18.30M | 61.06% | 2.28% |
| 5/14/2026 | 03/2026 | 3.44/-0.22 | 16.04M/16.34M | 1661.70% | -1.84% |
| 3/31/2026 | 12/2025 | -0.20/0.11 | 16.08M/26.17M | -285.45% | -38.56% |
| 11/14/2025 | 09/2025 | 0.13/-0.42 | 17.63M/21.02M | 132.12% | -16.12% |
| 8/14/2025 | 06/2025 | 0.50/-0.36 | 16.41M/14.53M | 238.01% | 12.93% |
| 5/15/2025 | 03/2025 | -0.48/-0.49 | 13.14M/11.62M | 2.89% | 13.07% |
| 3/31/2025 | 12/2024 | -0.37/-0.75 | 15.12M/16.30M | 50.75% | -7.22% |
| 11/14/2024 | 09/2024 | -0.76/-0.59 | 14.63M/32.22M | -28.33% | -54.59% |
Fortress Biotech Inc ææ°ã®æ±ºç®é»è©±äŒè°èšé²î
ãžã£ãŒããŒã»ã¡ãã£ã«ã«(FBIO) 2026幎第2ååæ決ç®èª¬æäŒïŒEmrosiã®å éã«äŒŽã売äžé«ã¯23%å¢å
ãžã£ãŒããŒã»ã¡ãã£ã«ã«ã®2026幎第2ååæ決ç®èª¬æäŒã§ã¯ã売äžé«ã23%å¢ã®1,850äžãã«ã«éããããšã調æŽåŸEBITDAãé»ååããããšãããã³Emrosiã®åŠæ¹ä»¶æ°ã®å éã匷調ãããŸããã